Characterization of the interactions of the pneumolysoid, Δ6 PLY, with human neutrophils in vitro

Vaccine

Volumn 29, Issue 48, 2011, Pages 8780-8782

  Cockeran, R ^a   Steel, H C ^a   Theron, A J ^a   Mitchell, T J ^b   Feldman, C ^c   Anderson, R ^a  

^a NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Calcium; Leukotriene B 4; Matrix metalloproteinase 9; Neutrophils; Pneumolysin

Indexed keywords

GELATINASE B; LEUKOTRIENE B4; PNEUMOCOCCUS VACCINE; PNEUMOLYSIN; PNEUMOLYSOID; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; CYTOSOL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IN VITRO STUDY; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN SECRETION; SPECTROFLUOROMETRY; WILD TYPE;

BACTERIAL PROTEINS; CALCIUM; CELLS, CULTURED; HUMANS; LEUKOTRIENE B4; MATRIX METALLOPROTEINASE 9; NEUTROPHIL ACTIVATION; NEUTROPHILS; STREPTOLYSINS; TOXOIDS;

EID: 82455162450     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.09.080     Document Type: Article

References (20)

1. Kadioglu A., Weiser J.N., Paton J.C., Andrew P.W. The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease. Nat Rev Microbiol 2008, 6:288-301.
2. Lu Y.J., Gross J., Bogaert D., Finn A., Bagrade L., Zhang Q., et al. Interleukin-17A mediates acquired immunity to pneumococcal colonization. PLoS Pathog 2008, 4:e1000159.
3. Zhang Z., Clarke T.B., Weiser J.N. Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice. J Clin Invest 2009, 119:1899-1909.
4. Malley R. Antibody and cell-mediated immunity to Streptococcus pneumoniae: implications for vaccine development. J Mol Med 2010, 88:135-142.
5. Marriott H.M., Mitchell T.J., Dockrell D.H. Pneumolysin: a double-edged sword during the host-pathogen interaction. Curr Mol Med 2008, 8:497-509.
6. Preston J.A., Dockrell D.H. Virulence factors in pneumococcal respiratory pathogenesis. Future Microbiol 2008, 3:205-221.
7. Feldman C., Munro N., Jeffery P.F., Mitchell T.J., Andrew P.W., Boulnois G.J., et al. Pneumolysin induces the salient histologic features of pneumococcal infection in the rat lung in vivo. Am J Respir Cell Mol Biol 1991, 5:416-423.
8. Briles D.E., Hollingshead S.K., Nabors G.S., Paton J.C., Brooks-Walter A. The potential for using protein vaccines to protect against otitis media caused by Streptococcus pneumoniae. Vaccine 2000, 19(Suppl. 1):587-595.
9. Coleman J.R., Papamichail D., Yano M., del Mar Garcia-Suarez M., Pirofski L.A. Designed reduction of Streptococcus pneumoniae pathogenicity via synthetic changes in virulence factor codon-pair bias. J Infect Dis 2011, 203:1264-1273.
10. Kirkham L.A.S., Kerr A.R., Douce G.R., Paterson G.K., Dilts D.A., Liu D.F., et al. Construction and immunological characterization of a novel non-toxic, protective pneumolysin mutant for use in future pneumococcal vaccines. Infect Immun 2006, 74:586-593.
11. Cockeran R., Theron A.J., Steel H.C., Matlola N.M., Mitchell T.J., Feldman C., et al. Pro-inflammatory interactions of pneumolysin with human neutrophils. J Infect Dis 2001, 183:604-611.
12. Ratner A.J., Hippe K.R., Aguilar J.L., Bender M.H., Nelson A.L., Weiser J.N. Epithelial cells are sensitive detectors of bacterial pore-forming toxins. J Biol Chem 2006, 281:12994-12998.
13. Saunders F.K., Mitchell T.J., Walker J.A., Andrew P.W., Boulnois G.J. Pneumolysin, the thiol-activated toxin of Streptococcus pneumoniae, does not require a thiol group for in vitro activity. Infect Immun 1989, 57:2547-2552.
14. Oloo E.O., Yethon J.A., Ochs M.M., Carpick B., Oomen R. Structure-guided antigen engineering yields pneumolysin mutants suitable for vaccination against pneumococcal disease. J Biol Chem 2011, 286:12133-12140.
15. Kim J.H., Suk M.H., Yoon D.W., Lee S.H., Hur G.Y., Jung K.H., et al. Inhibition of matrix metalloproteinase-9 prevents neutrophilic inflammation in ventilator-induced lung injury. Am J Physiol Lung Cell Mol Physiol 2006, 219:L580-L587.
16. 4 in allergic diseases. Allergol Int 2008, 57:291-298.
17. Cockeran R., Mitchell T.J., Feldman C., Anderson R. Pneumolysin induces release of matrix metalloproteinase-8 and -9 from human neutrophils. Eur Respir J 2010, 34:1167-1170.
18. 4 by human neutrophils. Infect Immun 2001, 69:3494-3496.
19. Lew P.D., Monod A., Waldvogel F.A., Dewald B., Baggiolini M., Pozzan T. Quantitative analysis of the cytosolic free calcium dependency of exocytosis from three subcellular compartments in intact human neutrophils. J Cell Biol 1986, 102:2197-2204.
20. Schatz-Munding M., Hatzelmann A., Ulrich V. The involvement of extracellular calcium in the formation of 5-lipoxygenase metabolites by human polymorphonuclear leukocytes. Eur J Biochem 1991, 197:487-493.